MarginsXMarginsX
Home › Markets › Health Care › BSX

Boston Scientific Corporation (BSX)

BSX trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$43.69
-1.47% on the day
Market cap
$63.3B
Large cap
Revenue · 2025
$20.1B
+19.9% on 2024
Net income · 2025
$2.9B
14.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/885725/000088572526000010/0000885725-26-000010-index.htm. Net income: SEC 10-K (us-gaap:ProfitLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerBSX on NYSE
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000885725
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$20.1B
Net income$2.9B
Operating income$3.6B
Net margin14.4%
Operating margin18.0%
Revenue growth+19.9%
Cash$2.0B
Total assets$43.7B
P/E (computed)21.9×
P/S (computed)3.2×

Warning signs

Cash runway
Cash-flow positive
$609.0M cash at September 30, 2026
Share count, 1 year
-2.2%
2025-10-30 to 2026-10-29 · -1.1% over 3 years
Going-concern doubt
No
10-Q filed November 2, 2026
Insider net buying, 12 months
-$19.2M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-02
Cash and burn$609.0M cash; operating cash flow $1.1B a quarter.Report 2026-09-30
Shares outstanding1,449,473,222 (2026-10-29); 1,482,442,039 a year earlier; 1,464,982,777 three years earlier.Cover page 2026-10-29
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2026-03-06
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $10.0M, sold $29.3M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$5.1B$580.0M$1.0B$609.0M$12.0B$21.1B10-Q 2026-11-02
Q2 2026
2026-06-30
$5.4B$905.0M$1.5B$539.0M$12.6B$21.0B10-Q 2026-08-03
Q1 2026
2026-03-31
$5.2B$1.3B$348.0M$1.5B$11.0B$20.6B10-Q 2026-05-01
Q4 2025
2025-12-31
$5.3B$670.0M$1.4B$2.0B$11.4B$20.1B10-K 2026-02-17
Q3 2025
2025-09-30
$5.1B$755.0M$1.3B$1.3B$11.6B$19.4B10-Q 2026-11-02
Q2 2025
2025-06-30
$5.1B$795.0M$1.3B$534.0M$11.6B$18.5B10-Q 2026-08-03
Q1 2025
2025-03-31
$4.7B$672.0M$541.0M$725.0M$11.3B$17.6B10-Q 2026-05-01
Q4 2024
2024-12-31
$4.6B$562.0M$1.5B$414.0M$10.7B$16.7B10-K 2026-02-17

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-04-01
Latest annual report10-K2026-02-17
Latest quarterly / interim10-Q2026-11-02
Latest current report8-K2026-10-28
Latest proxyDEFA14A2026-03-18

Source: SEC EDGAR submissions feed, 1,003 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+3.7%
1 month+2.4%
3 months-14.2%
Year to date-53.5%
1 year-57.8%
From 52-week high-56.8%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
BDXBecton Dickinson and Company$216.47-0.72%$59.0B
MDLNMedline Inc.$39.17-0.76%$51.5B
MMM3M Company$181.68-1.08%$93.9B
SYKStryker Corporation$310.72+0.35%$118.3B
RMDResMed Inc.$238.19-0.56%$33.5B
DXCMDexCom Inc.$81.61-2.06%$30.4B
WSTWest Pharmaceutical Services Inc.$417.80+0.33%$29.1B
SOLVSolventum Corporation$88.65-0.48%$15.0B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier